IBDEI08R ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,3630,0)
 ;;=305.41^^11^157^24
 ;;^UTILITY(U,$J,358.3,3630,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3630,1,2,0)
 ;;=2^305.41
 ;;^UTILITY(U,$J,358.3,3630,1,5,0)
 ;;=5^Anxiolytic Abuse, Continuous
 ;;^UTILITY(U,$J,358.3,3630,2)
 ;;=^331936
 ;;^UTILITY(U,$J,358.3,3631,0)
 ;;=305.42^^11^157^25
 ;;^UTILITY(U,$J,358.3,3631,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3631,1,2,0)
 ;;=2^305.42
 ;;^UTILITY(U,$J,358.3,3631,1,5,0)
 ;;=5^Anxiolytic Abuse, Episodic
 ;;^UTILITY(U,$J,358.3,3631,2)
 ;;=^331937
 ;;^UTILITY(U,$J,358.3,3632,0)
 ;;=305.51^^11^157^69
 ;;^UTILITY(U,$J,358.3,3632,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3632,1,2,0)
 ;;=2^305.51
 ;;^UTILITY(U,$J,358.3,3632,1,5,0)
 ;;=5^Opioid Abuse, Continuous
 ;;^UTILITY(U,$J,358.3,3632,2)
 ;;=^268244
 ;;^UTILITY(U,$J,358.3,3633,0)
 ;;=305.52^^11^157^70
 ;;^UTILITY(U,$J,358.3,3633,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3633,1,2,0)
 ;;=2^305.52
 ;;^UTILITY(U,$J,358.3,3633,1,5,0)
 ;;=5^Opioid Abuse, Episodic
 ;;^UTILITY(U,$J,358.3,3633,2)
 ;;=^268245
 ;;^UTILITY(U,$J,358.3,3634,0)
 ;;=305.61^^11^157^40
 ;;^UTILITY(U,$J,358.3,3634,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3634,1,2,0)
 ;;=2^305.61
 ;;^UTILITY(U,$J,358.3,3634,1,5,0)
 ;;=5^Cocaine Abuse, Continuous
 ;;^UTILITY(U,$J,358.3,3634,2)
 ;;=^268247
 ;;^UTILITY(U,$J,358.3,3635,0)
 ;;=305.62^^11^157^41
 ;;^UTILITY(U,$J,358.3,3635,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3635,1,2,0)
 ;;=2^305.62
 ;;^UTILITY(U,$J,358.3,3635,1,5,0)
 ;;=5^Cocaine Abuse, Episodic
 ;;^UTILITY(U,$J,358.3,3635,2)
 ;;=^268248
 ;;^UTILITY(U,$J,358.3,3636,0)
 ;;=305.71^^11^157^16
 ;;^UTILITY(U,$J,358.3,3636,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3636,1,2,0)
 ;;=2^305.71
 ;;^UTILITY(U,$J,358.3,3636,1,5,0)
 ;;=5^Amphetamine Abuse, Continuous
 ;;^UTILITY(U,$J,358.3,3636,2)
 ;;=^268251
 ;;^UTILITY(U,$J,358.3,3637,0)
 ;;=305.72^^11^157^17
 ;;^UTILITY(U,$J,358.3,3637,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3637,1,2,0)
 ;;=2^305.72
 ;;^UTILITY(U,$J,358.3,3637,1,5,0)
 ;;=5^Amphetamine Abuse, Episodic
 ;;^UTILITY(U,$J,358.3,3637,2)
 ;;=^268252
 ;;^UTILITY(U,$J,358.3,3638,0)
 ;;=305.91^^11^157^77
 ;;^UTILITY(U,$J,358.3,3638,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3638,1,2,0)
 ;;=2^305.91
 ;;^UTILITY(U,$J,358.3,3638,1,5,0)
 ;;=5^Other Drug Abuse, Continuous
 ;;^UTILITY(U,$J,358.3,3638,2)
 ;;=^268259
 ;;^UTILITY(U,$J,358.3,3639,0)
 ;;=305.92^^11^157^78
 ;;^UTILITY(U,$J,358.3,3639,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3639,1,2,0)
 ;;=2^305.92
 ;;^UTILITY(U,$J,358.3,3639,1,5,0)
 ;;=5^Other Drug Abuse, Episodic
 ;;^UTILITY(U,$J,358.3,3639,2)
 ;;=^268260
 ;;^UTILITY(U,$J,358.3,3640,0)
 ;;=304.03^^11^157^72
 ;;^UTILITY(U,$J,358.3,3640,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3640,1,2,0)
 ;;=2^304.03
 ;;^UTILITY(U,$J,358.3,3640,1,5,0)
 ;;=5^Opioid Dep-Remission
 ;;^UTILITY(U,$J,358.3,3640,2)
 ;;=^268193
 ;;^UTILITY(U,$J,358.3,3641,0)
 ;;=V65.2^^11^158^35
 ;;^UTILITY(U,$J,358.3,3641,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3641,1,2,0)
 ;;=2^V65.2
 ;;^UTILITY(U,$J,358.3,3641,1,5,0)
 ;;=5^Malingering
 ;;^UTILITY(U,$J,358.3,3641,2)
 ;;=^92393
 ;;^UTILITY(U,$J,358.3,3642,0)
 ;;=V65.49^^11^158^3
 ;;^UTILITY(U,$J,358.3,3642,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3642,1,2,0)
 ;;=2^V65.49
 ;;^UTILITY(U,$J,358.3,3642,1,5,0)
 ;;=5^Counseling,Oth Specified
 ;;^UTILITY(U,$J,358.3,3642,2)
 ;;=^303471
 ;;^UTILITY(U,$J,358.3,3643,0)
 ;;=V61.10^^11^158^43
 ;;^UTILITY(U,$J,358.3,3643,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3643,1,2,0)
 ;;=2^V61.10
 ;;^UTILITY(U,$J,358.3,3643,1,5,0)
 ;;=5^Partner Relational Problem
 ;;
 ;;$END ROU IBDEI08R
